一名囊性纤维化患者发生严重的哌拉西林-他唑巴坦诱导的溶血。
Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient.
作者信息
Kerkhoff Andrew D, Patrick Lauren, Cornett Patricia, Kleinhenz Mary-Ellen, Brondfield Sam
机构信息
Department of Medicine University of California San Francisco School of Medicine San Francisco California.
Department of Neurology University of California San Francisco School of Medicine San Francisco California.
出版信息
Clin Case Rep. 2017 Nov 2;5(12):2059-2061. doi: 10.1002/ccr3.1256. eCollection 2017 Dec.
Abstract
Piperacillin-tazobactam is one of the most common causes of drug-induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life-threatening piperacillin-tazobactam-associated DIIHA in a 30-year-old woman with CF and propose management recommendations for piperacillin-tazobactam-associated DIIHA in CF patients.
摘要
哌拉西林-他唑巴坦是药物性免疫性溶血性贫血（DIIHA）最常见的病因之一，且经常被使用，尤其是在囊性纤维化（CF）患者中。在此，我们报告一例30岁患有CF的女性发生危及生命的哌拉西林-他唑巴坦相关性DIIHA的病例，并提出CF患者中哌拉西林-他唑巴坦相关性DIIHA的管理建议。
相似文献
1
Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient.
Clin Case Rep. 2017 Nov 2;5(12):2059-2061. doi: 10.1002/ccr3.1256. eCollection 2017 Dec.
2
Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
Case Rep Med. 2010;2010:161454. doi: 10.1155/2010/161454. Epub 2010 Jun 2.
3
Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review.
BMC Nephrol. 2023 Jun 14;24(1):173. doi: 10.1186/s12882-023-03235-w.
4
Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
Transfusion. 2019 Dec;59(12):3746-3754. doi: 10.1111/trf.15591. Epub 2019 Nov 14.
5
Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.
BMJ Case Rep. 2016 Oct 24;2016:bcr2016216937. doi: 10.1136/bcr-2016-216937.
6
Hemolytic anemia as a result of piperacillin/tazobactam administration: a case report and discussion of pathophysiology.
Mil Med. 2013 Sep;178(9):e1045-7. doi: 10.7205/MILMED-D-12-00512.
7
Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.
Infection. 2010 Apr;38(2):131-4. doi: 10.1007/s15010-009-9227-8. Epub 2010 Mar 5.
8
Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient.
J Cyst Fibros. 2010 Dec;9(6):433-8. doi: 10.1016/j.jcf.2010.08.010. Epub 2010 Sep 15.
9
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Pediatr Pulmonol. 2017 Aug;52(8):1000-1005. doi: 10.1002/ppul.23718. Epub 2017 Apr 25.
10
Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.
J Antimicrob Chemother. 2014 Jan;69(1):176-9. doi: 10.1093/jac/dkt300. Epub 2013 Jul 18.
引用本文的文献
1
[In macrohematuria, medication history also needs to be considered : Penicillin-induced immune hemolysis: a case report and review of literature].
Inn Med (Heidelb). 2023 Dec;64(12):1218-1223. doi: 10.1007/s00108-023-01555-5. Epub 2023 Jul 26.
2
The First-Reported Case of Drug-Induced Hemolytic Anemia by Piperacillin-Tazobactam in a Premature Neonate: A Case Report and Literature Review.
Cureus. 2023 Mar 8;15(3):e35915. doi: 10.7759/cureus.35915. eCollection 2023 Mar.
本文引用的文献
1
Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.
BMJ Case Rep. 2016 Oct 24;2016:bcr2016216937. doi: 10.1136/bcr-2016-216937.
2
Pulmonary Exacerbations in Children with Cystic Fibrosis.
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S200-6. doi: 10.1513/AnnalsATS.201502-098AW.
3
Pathology consultation on drug-induced hemolytic anemia.
Am J Clin Pathol. 2011 Jul;136(1):7-12. doi: 10.1309/AJCPBVLJZH6W6RQM.
4
Immune hemolytic anemia associated with drug therapy.
Blood Rev. 2010 Jul-Sep;24(4-5):143-50. doi: 10.1016/j.blre.2010.06.004. Epub 2010 Jul 21.
5
Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
Case Rep Med. 2010;2010:161454. doi: 10.1155/2010/161454. Epub 2010 Jun 2.
6
Piperacillin-induced immune hemolysis: new cases and a concise review of the literature.
Transfusion. 2010 May;50(5):1135-8. doi: 10.1111/j.1537-2995.2009.02544.x. Epub 2009 Dec 29.
7
Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.
Am J Med. 1990 Aug;89(2):161-8. doi: 10.1016/0002-9343(90)90294-n.
Zotero 插件